Reckitt Benckiser Group PLC (OTCMKTS:RBGLY – Get Free Report) was the target of a significant drop in short interest in the month of July. As of July 31st, there was short interest totaling 332,874 shares, a drop of 38.4% from the July 15th total of 540,185 shares. Based on an average trading volume of 1,142,775 shares, the days-to-cover ratio is currently 0.3 days. Approximately 0.0% of the shares of the stock are short sold.
Analyst Ratings Changes
RBGLY has been the subject of a number of research reports. Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating on shares of Reckitt Benckiser Group in a research note on Tuesday, June 30th. Jefferies Financial Group upgraded Reckitt Benckiser Group from a “hold” rating to a “buy” rating in a report on Tuesday, July 21st. Finally, Zacks Research lowered Reckitt Benckiser Group from a “hold” rating to a “strong sell” rating in a report on Thursday, July 30th. Two equities research analysts have rated the stock with a Strong Buy rating, three have assigned a Buy rating, two have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy”.
View Our Latest Analysis on RBGLY
Reckitt Benckiser Group Price Performance
About Reckitt Benckiser Group
Reckitt Benckiser Group plc is a multinational consumer goods company that develops, manufactures and markets health, hygiene and home products. Its portfolio spans over-the-counter medicines and health products, personal and sexual wellness, surface and laundry cleaning, and household care. The company owns a number of well-known global brands across these categories, including Lysol and Dettol in disinfectants and hygiene, Durex in sexual wellness, Nurofen in analgesics, and Finish in dishwashing products.
The firm has its corporate headquarters in the United Kingdom and sells products in markets around the world, serving consumers across North America, Europe, Asia, Latin America, the Middle East and Africa.
Featured Stories
- Five stocks we like better than Reckitt Benckiser Group
- Bloom Energy’s AI Surge Meets a Valuation Reality Check
- Target Is Winning Shoppers Back—Can the Rally Reach $180?
- IonQ’s Space Contract Points to a New Frontier for Quantum Investors
- Is Apple’s AI Strategy Smarter Than Skeptics Think?
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.
